Fundraising Fox

Brainsway

Jerusalem, US · Israel corporation

BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Founders & leadership

HLHadar Levy
Hadar LevyinChief Executive Officer
IMIdo Marom
Ido MarominCFO
AZ
Abraham ZangenNamed on SEC filing

Board

YB
Yossi Ben ShalomBoard director
AH
Avner HagaiBoard director
DZ
David ZacutVice Chairman of the Board of Directors
EM
Eti MitranyBoard director
KS
Karen SaridBoard director
AB
Ami BoehmChairman of the Board of Directors
AL
Avner LushiBoard director

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2024

▶$20MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hadar LevyExecutive Officer
  • Yossi Ben ShalomDirector
  • Avner HagaiDirector
  • David ZacutDirector
  • Ido MaromExecutive Officer
  • Abraham ZangenDirector
  • Eti MitranyDirector
  • Karen SaridDirector
  • Ami BoehmDirector
  • Avner LushiDirector
Offering amount
$20M
Amount sold
$20M
First sale
Sep 2024
Incorporated
Corporation, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Psychcentral3832 shared keywordsPsych Central is a digital publisher providing informational content on mental health, wellness, and medical topics developed in collaboration with licensed medical professionals. The company serves general audiences seeking educational resources on health conditions and treatments.

Companies competing with Brainsway for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Brainsway Q2 Earnings Call Highlights | MarketBeatmarketbeat.com · Aug 2026Brainsway stock price target raised to $20 by BTIG on revenue beat By Investing.comin.investing.com · Aug 2026

Frequently asked questions

What does Brainsway do?
BrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.
How much funding has Brainsway raised?
Brainsway has disclosed $20M raised across 1 round.
Where is Brainsway headquartered?
Brainsway is headquartered in Jerusalem, US.